Literature DB >> 19332721

CSF antithrombin III and disruption of the blood-brain barrier.

Henrik Zetterberg, Ulf Andreasson, Kaj Blennow.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19332721     DOI： 10.1200/JCO.2008.19.8598

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

Review 1.  Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors.

Authors:  Severa Bunda; Jeffrey A Zuccato; Mathew R Voisin; Justin Z Wang; Farshad Nassiri; Vikas Patil; Sheila Mansouri; Gelareh Zadeh
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

2.  Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma.

Authors:  Milla Elvi Linnea Kuusisto; Kirsi-Maria Haapasaari; Anne Marja Remes; Risto Bloigu; Peeter Karihtala; Taina Turpeenniemi-Hujanen; Outi Kuittinen
Journal:  Ann Hematol       Date:  2015-02-21       Impact factor: 3.673

Review 3.  Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies.

Authors:  Tarek Shalaby; Michael A Grotzer
Journal:  Int J Mol Sci       Date:  2015-12-07       Impact factor: 5.923

4.  Proteomic changes in cerebrospinal fluid from primary central nervous system lymphoma patients are associated with protein ectodomain shedding.

Authors:  Uwe Schlegel; Kai Stühler; Daniel Michael Waldera-Lupa; Omid Etemad-Parishanzadeh; Mareike Brocksieper; Nina Kirchgaessler; Sabine Seidel; Thomas Kowalski; Manuel Montesinos-Rongen; Martina Deckert
Journal:  Oncotarget       Date:  2017-11-24

5.  A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry.

Authors:  Daniel M Waldera-Lupa; Gereon Poschmann; Nina Kirchgaessler; Omid Etemad-Parishanzadeh; Falk Baberg; Mareike Brocksieper; Sabine Seidel; Thomas Kowalski; Anna Brunn; Aiden Haghikia; Ralf Gold; Anja Stefanski; Martina Deckert; Uwe Schlegel; Kai Stühler
Journal:  Cancers (Basel)       Date:  2020-06-29       Impact factor: 6.639

6.  Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review.

Authors:  Anouk van Westrhenen; Lisanne C A Smidt; Tatjana Seute; Stefan Nierkens; Abraham C J Stork; Monique C Minnema; Tom J Snijders
Journal:  Br J Haematol       Date:  2018-05-29       Impact factor: 6.998

Review 7.  Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery.

Authors:  Yang Woo Kwon; Han-Seul Jo; Sungwon Bae; Youngsuk Seo; Parkyong Song; Minseok Song; Jong Hyuk Yoon
Journal:  Front Med (Lausanne)       Date:  2021-09-22

8.  High CSF thrombin concentration and activity is associated with an unfavorable outcome in patients with intracerebral hemorrhage.

Authors:  Harald Krenzlin; Christina Frenz; Jan Schmitt; Julia Masomi-Bornwasser; Dominik Wesp; Darius Kalasauskas; Thomas Kerz; Johannes Lotz; Beat Alessandri; Florian Ringel; Naureen Keric
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.